SCHEMBL1261297

SCHEMBL1261297

CCCCCCCCCCCCCCCCCC(CC)OP(O)O

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
DNM1 Q05193 2/20 0.39
SMPD1 P17405 3/20 0.37
GPR84 Q9NQS5 3/20 0.36
FDPS P14324 3/20 0.36
SPHK1 Q9NYA1 1/20 0.36
FFAR1 O14842 1/20 0.36
ZDHHC7 Q9NXF8 1/20 0.36
MAPT P10636 1/20 0.35
LCK P06239 1/20 0.35
PPARD Q03181 1/20 0.35
ZDHHC20 Q5W0Z9 1/20 0.35
ZDHHC2 Q9UIJ5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11060411 1.00 LMNA (0.40) LMNADNM1SMPD1GPR84FDPS
SCHEMBL1260707 1.00 LMNA (0.40) LMNADNM1SMPD1GPR84FDPS
SCHEMBL1261495 1.00 LMNA (0.40) LMNADNM1SMPD1GPR84FDPS
SCHEMBL1259447 1.00 LMNA (0.40) LMNADNM1SMPD1GPR84FDPS
SCHEMBL5678037 0.98 LMNA (0.37) LMNADNM1SMPD1GPR84FDPS
SCHEMBL31174518 0.91 LMNA (0.43) LMNADNM1SMPD1GPR84FDPS
SCHEMBL9605657 0.91 LMNA (0.43) LMNADNM1SMPD1GPR84FDPS
SCHEMBL31131432 0.91 LMNA (0.43) LMNADNM1SMPD1GPR84FDPS
SCHEMBL4451467 0.91 LMNA (0.43) LMNADNM1SMPD1GPR84FDPS
SCHEMBL28367128 0.91 LMNA (0.43) LMNADNM1SMPD1GPR84FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017562-B2 Gelled hydrocarbons for oilfield processes, phosphate ester compounds useful in gellation of hydrocarbons and methods for production and use thereof BRINE-ADD FLUIDS LTD. (CA) 2011-09-13 US disclosed
US-7972996-B2 Gelled hydrocarbons for oilfield processes, phosphate ester compounds useful in gellation of hydrocarbons and methods for production and use thereof Brine-Add Fluids Ltd (CA) 2011-07-05 US disclosed
US-7947632-B2 Gelled hydrocarbons for oilfield processes, phosphate ester compounds useful in gellation of hydrocarbons and methods for production and use thereof BRINE-ADD FLUIDS LTD. (CA) 2011-05-24 US disclosed
US-20110100633-A1 GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF BRINE-ADD FLUIDS LTD. (CA) 2011-05-05 US disclosed
US-20110046408-A1 GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF BRINE-ADD FLUIDS LTD. (CA) 2011-02-24 US disclosed
US-20090203556-A1 GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF BRINE-ADD FLUIDS LTD. (CA) 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046408-A1 GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF DAGLA, PHOSPHO1, DGKG LMNA 2892/4885DNM1 2740/4885SMPD1 1056/4885
US-20090203556-A1 GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF DAGLA, PHOSPHO1, DGKG LMNA 2892/4885DNM1 2740/4885SMPD1 1056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.